Strategic Acquisition IBA Dosimetry recently expanded its US footprint and product offering through the Radcal acquisition, creating cross-sell opportunities for Radcal’s X-ray imaging capabilities alongside IBA’s QA and dosimetry solutions for radiology and radiotherapy.

Integrated QA Platform The myQA iON platform and enhanced myQA Machines ecosystem position IBA Dosimetry as a comprehensive QA stack. This enables upsell of modular QA software and services to hospitals consolidating vendors for radiotherapy and imaging QA.

Global Footprint Headquartered in Germany with subsidiaries in the US and China, IBA Dosimetry has a broad regional reach that allows tailored regional sales strategies, channel partnerships, and service contracts in key markets.

Strong Trust Signals As the world’s leading dosimetry solution provider with a focus on precision and safety, IBA Dosimetry can leverage its reputation to cross-sell training, calibration services, and maintenance agreements to existing hospital customers.

Growth Through Innovation Ongoing software and product launches (myQA iON, ProMed related expansions) indicate a pipeline of new features and modules—opportunity to position upgrades, licensing, and renewal cycles as recurring revenue with current and new customers.